# US 2015/0031760 A1 · Pharmaceutical composition for preventing or treating nervous system disorders comprising sulfuretin or pharmaceutically acceptable salt thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0031760 A1
- Document ID: US20150031760A1
- Status: Published application
- Kind: A1
- Application number: 14/479,973
- Filed: 2014-09-08
- Published: 2015-01-29
- Earliest claimed: 2010-03-26
- Assignees: Research & Business Foundation Sungkyunkwan University
- Applicants: Research and Business Foundation SUNGKYUNKWAN UNIVERSITY
- Inventors: Choon Gon JANG
- Web page: https://patentgrep.com/patent/US20150031760A1

## CPC

- A61K 31/343: condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a pharmaceutical composition for preventing or treating nervous system disorders, which contains sulfuretin or a pharmaceutically acceptable salt thereof, and a method of using the composition to prevent or treat nervous system disorders. Moreover, the present invention relates to a functional food composition for alleviating nervous system disorders, which contains sulfuretin or a pharmaceutically acceptable salt thereof. The pharmaceutical composition and the functional food composition can be effectively used to prevent or treat degenerative brain disorders caused by a variety of cerebral nervous system abnormalities in persons, as well as depressive disorder and anxiety.

## Claims

### Claim 1

A method of preventing or treating a nervous system disorder by administering a pharmaceutical composition comprising an isolated sulfuretin or a pharmaceutically acceptable salt thereof to a subject having or being at risk of developing a nervous system disorder.

### Claim 2 (depends on 1)

The method of claim 1, wherein the nervous system disorder is selected from the group consisting of dementia, Alzheimer's disease, Parkinson's disease, stroke, depressive disorders and anxiety.

### Claim 3 (depends on 1)

The method of claim 1, wherein the composition further comprises a pharmaceutically acceptable carrier.
